ViVest is a pioneering medical technology company at the forefront of advancing the prevention and treatment of ventricular arrhythmia, as well as providing cutting-edge cardiac rhythm data services. Our unwavering commitment lies in delivering comprehensive and groundbreaking solutions for the global prevention, monitoring, treatment, and rehabilitation of ventricular arrhythmia. Leveraging the groundbreaking innovation of wearable cardioverter defibrillators and recognizing the pressing clinical imperatives, ViVest has achieved a historic milestone as the first company in China to independently develop wearable cardioverter defibrillators (WCDs). Looking ahead, our vision extends to the creation of the world's premier multi-parameter sudden cardiac death risk assessment system, propelled by the promotion of wearable ventricular arrhythmia products and remote data service management. This forward-looking approach positions ViVest at the vanguard of transforming the treatment of sudden cardiac death, shifting from passive response to precise treatment of ventricular arrhythmia rhythm management, seamlessly integrating prevention and treatment.